These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18084343)

  • 1. New therapeutic approaches to treat medullary thyroid carcinoma.
    Schlumberger M; Carlomagno F; Baudin E; Bidart JM; Santoro M
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):22-32. PubMed ID: 18084343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma.
    Leboulleux S; Baudin E; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):299-310. PubMed ID: 15355445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of medullary thyroid carcinoma.
    Massoll N; Mazzaferri EL
    Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of medullary thyroid cancer.
    Ball DW
    Minerva Endocrinol; 2011 Mar; 36(1):87-98. PubMed ID: 21460789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Bianchi V; Rovera F; Boni L; Piantanida E; Tanda ML; Dionigi R; Bartalena L
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):877-85. PubMed ID: 17555398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid cancer.
    You YN; Lakhani V; Wells SA; Moley JF
    Surg Oncol Clin N Am; 2006 Jul; 15(3):639-60. PubMed ID: 16882502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of microcarcinomas (papillary and medullary) of the thyroid.
    Wu LS; Milan SA
    Curr Opin Oncol; 2013 Jan; 25(1):27-32. PubMed ID: 23042124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
    Austin JR; el-Naggar AK; Goepfert H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
    Messina M; Robinson BG
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.
    Sakorafas GH; Friess H; Peros G
    Endocr Relat Cancer; 2008 Dec; 15(4):871-84. PubMed ID: 19015274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.
    Drosten M; Pützer BM
    Nat Clin Pract Oncol; 2006 Oct; 3(10):564-74. PubMed ID: 17019434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid cancer: molecular biology and novel molecular therapies.
    Cakir M; Grossman AB
    Neuroendocrinology; 2009; 90(4):323-48. PubMed ID: 19468197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid cancer: monitoring and therapy.
    Ball DW
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):823-37, viii. PubMed ID: 17673130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.